Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2

被引：158

作者：

Dearth, Robert K.

Cui, Xiaojiang

Kim, Hyun-Jung

Hadsell, Darryl L.

Lee, Adrian V. ^{[1
]}

机构：

[1] Baylor Coll Med, Breast Ctr, Dept Med, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA

[3] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA

来源：

CELL CYCLE | 2007年 / 6卷 / 06期

关键词：

insulin receptor substrate; IRS-1; IRS-2; breast cancer; mammary gland; transgenic mouse; cancer; transformation; oncogene;

D O I：

10.4161/cc.6.6.4035

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Insulin receptor substrates (IRSs) are adaptor proteins that link signaling from upstream activators to multiple downstream effectors to modulate normal growth, metabolism, survival, and differentiation. Recent cell culture studies have shown that IRSs can interact with, and are functionally required for, the transforming ability of many oncogenes. Consistent with this, IRSs are elevated and hyperactive in many human tumors. IRSs respond to many extracellular signals that are critical for mammary gland development, and we have shown that IRSs disrupt normal mammary acini formation in vitro, and cause mammary tumorigenesis and metastasis in vivo. In this review we will discuss the role of IRSs in both transformation and cancer progression.

引用

收藏

页码：705 / 713

页数：9

相关论文

共 154 条

[1] The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J].

Aguirre, V ;

Uchida, T ;

Yenush, L ;

Davis, R ;

White, MF .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :9047-9054

[2] The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse [J].

Alexander, WS ;

Hilton, DJ .

ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :503-529

[3] Insulin receptor substrate proteins create a link between the tyrosine phosphorylation cascade and the Ca2+-ATPases in muscle and heart [J].

Algenstaedt, PM ;

Antonetti, DA ;

Yaffe, MB ;

Kahn, CR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23696-23702

[4] p130Cas mediates the transforming properties of the anaplastic lymphoma kinase [J].

Ambrogio, C ;

Voena, C ;

Manazza, AD ;

Piva, R ;

Riera, L ;

Barberis, L ;

Costa, C ;

Tarone, G ;

Defilippi, P ;

Hirsch, E ;

Erba, EB ;

Mohammed, S ;

Jensen, ON ;

Palestro, G ;

Inghirami, G ;

Chiarle, R .

BLOOD, 2005, 106 (12) :3907-3916

[5] Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells [J].

Amoui, M ;

Craddock, BP ;

Miller, WT .

JOURNAL OF ENDOCRINOLOGY, 2001, 171 (01) :153-162

[6] ALTERNATIVE PATHWAY OF INSULIN SIGNALING IN MICE WITH TARGETED DISRUPTION OF THE IRS-1 GENE [J].

ARAKI, E ;

LIPES, MA ;

PATTI, ME ;

BRUNING, JC ;

HAAG, B ;

JOHNSON, RS ;

KAHN, CR .

NATURE, 1994, 372 (6502) :186-190

[7] Active Rho kinase (ROK-α) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells [J].

Begum, N ;

Sandu, OA ;

Ito, M ;

Lohmann, SM ;

Smolenski, A .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6214-6222

[8] The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS - Modulation by insulin growth factor-1 (IGF) and enhanced IGF-1 signaling [J].

BeitnerJohnson, D ;

Blakesley, VA ;

ShenOrr, Z ;

Jimenez, M ;

Stannard, B ;

Wang, LM ;

Pierce, J ;

LeRoith, D .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) :9287-9290

[9] A role for the scaffolding adapter GAB2 in breast cancer [J].

Bentires-Alj, M ;

Gil, SG ;

Chan, R ;

Wang, ZGC ;

Wang, YP ;

Imanaka, N ;

Harris, LN ;

Richardson, A ;

Neel, BG ;

Gu, HH .

NATURE MEDICINE, 2006, 12 (01) :114-121

[10] Increased expression of insulin receptor substrate-1 in human pancreatic cancer [J].

Bergmann, U ;

Funatomi, H ;

Kornmann, M ;

Beger, HG ;

Korc, M .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (03) :886-890

← 1 2 3 4 5 6 7 8 9 10 →